retatrutide phase 2 trial obesity triple agonist gip glp-1 glucagon Eli Lilly's shows promising weight loss results in 3 Retatrutide vs. Tirzepatide: The Next-Gen – retatrutide triple agonist phase 2
Pay in 4 interest-free payments of $6.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30

























